(Q47974165)

English

Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coron

scientific article published in June 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coron (English)

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

myocardial infarction

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Paul W. Armstrong

5

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

10

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

9

object named as

Califf RM

1 reference

Europe PubMed Central

7 February 2018

Christopher B. Granger

3

object named as

Granger CB

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

Harvey D. White

2

object named as

White HD

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

author name string

Metz BK

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

Simes RJ

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

Hirsh J

6

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

Fuster V

7

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

MacAulay CM

8

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

language of work or name

0 references

publication date

1 June 1998

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

31

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

7

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

1493-1498

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombin Generation, Inhibition and Clinical Outcomes in Patients With Acute Myocardial Infarction Treated With Thrombolytic Therapy and Heparin: Results From the GUSTO-I Trial fn1fn1This study was supported by Genentech, Inc., South San Francisco, C

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Issues Regarding the Use of Heparin Following Streptokinase Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900138-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(98)00138-7

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9626825

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47974165&oldid=2063428520"